By Using Adoptive Transfer of Autologous NK Cells to Prevent Recurrence of Hepatocellular Carcinoma After Curative Therapy
Clinical trial NCT02725996 · UNKNOWN
Trial details
- NCT number
- NCT02725996
- Sponsor
- Southwest Hospital, China
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2018-04-01
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.